Factors influencing lithium versus valproate prescription preference in the maintenance treatment of bipolar patients: a report from the Italian Early Career Psychiatrists (SOPSI-GG)

References

• Altamura AC, Buoli M, Cesana BM, Fagiolini A, de Bartolomeis A, Maina G, Bellomo A, Dell’Osso B, ISBD Italian Chapter Epidemiological Group. 2019. Psychotic versus non-psychotic bipolar disorder: Socio-demographic and clinical profiles in an Italian nationwide study. Aust N Z J Psychiatry. 53(8):772–781. doi:10.1177/0004867418823268
   PubMed Web of Science ®Google Scholar
• Andrade C. 2018. Valproate in Pregnancy: Recent Research and Regulatory Responses. J Clin Psychiatry. 79:18f12351. doi:10.4088/JCP.18f12351
   PubMed Web of Science ®Google Scholar
• Angst J, Merikangas KR, Cui L, Van Meter A, Ajdacic-Gross V, Rössler W. 2018. Bipolar spectrum in major depressive disorders. Eur Arch Psychiatry Clin Neurosci. 268(8):741–748. doi:10.1007/s00406-018-0927-x
   PubMed Web of Science ®Google Scholar
• Baggiani G, Ambrosiani L, Trincas P, Burrai C, Bocchetta A. 2018. Psychotropic Medication of Acute Episodes of Mood Disorders: Current Prescription Attitude in Two Psychiatric Wards in Cagliari, Italy. Clin Pract Epidemiol Ment Health. 14:236–249. doi:10.2174/1745017901814010236
   PubMedGoogle Scholar
• Barlati S, Buoli M, Di Giorgio A, Di Lorenzo G, Gramaglia C, Gattoni E, Aguglia A, Monteleone AM, Dell’Osso B. 2019. Assessing learning needs and career attitudes of Italian psychiatry residents: results from a national survey conducted by the Italian Society of Psychopathology Young Psychiatrists Section (SOPSI-GG). CPEMH. 15(1):21–29. doi:10.2174/1745017901915010021
   Google Scholar
• Berk M, Post R, Ratheesh A, Gliddon E, Singh A, Vieta E, Carvalho AF, Ashton MM, Berk L, Cotton SM, McGorry PD, et al. 2017. Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry. 16(3):236–244. doi:10.1002/wps.20441
   PubMed Web of Science ®Google Scholar
• Buoli M, Serati M, Altamura AC. 2014. Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review. J Affect Disord. 152–154:12–18. doi:10.1016/j.jad.2013.08.024
   PubMed Web of Science ®Google Scholar
• Buoli M, Serati M, Botturi A, Altamura AC. 2018. The risk of thrombocytopenia during valproic acid therapy: a critical summary of available clinical data. Drugs R D. 18(1):1–5. doi:10.1007/s40268-017-0224-6
   PubMed Web of Science ®Google Scholar
• Cipriani A, Reid K, Young AH, Macritchie K, Geddes J. 2013. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev. 10:CD003196. doi:10.1002/14651858.CD003196
   Google Scholar
• Cohen JM, Huybrechts KF, Patorno E, Desai RJ, Mogun H, Bateman BT, Hernández-Díaz S. 2019. Anticonvulsant mood stabilizer and lithium use and risk of adverse pregnancy outcomes. J Clin Psychiatry. 80:18m12572. doi:10.4088/JCP.18m12572
   PubMed Web of Science ®Google Scholar
• Colom F, Vieta E, Daban C, Pacchiarotti I, Sánchez-Moreno J. 2006. Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord. 93(1–3):13–17. doi:10.1016/j.jad.2006.01.032
   PubMed Web of Science ®Google Scholar
• Deligiannidis KM, Byatt N, Freeman MP. 2014. Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. J Clin Psychopharmacol. 34(2):244–255. doi:10.1097/JCP.0000000000000087
   PubMed Web of Science ®Google Scholar
• Fiorillo A, Sampogna G, Del Vecchio V, Luciano M, Ambrosini A, Stanghellini G. 2016. Education in Psychopathology in Europe: results from a Survey in 32 Countries. Acad Psychiatry. 40(2):242–248. doi:10.1007/s40596-015-0333-x
   PubMed Web of Science ®Google Scholar
• Fornaro M, Maritan E, Ferranti R, Zaninotto L, Miola A, Anastasia A, Murru A, Solé E, Stubbs B, Carvalho AF, et al. 2020. Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes. AJP. 177(1):76–92. doi:10.1176/appi.ajp.2019.19030228
   Google Scholar
• Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. 2013. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 14(3):154–219. doi:10.3109/15622975.2013.770551
   PubMed Web of Science ®Google Scholar
• Hirschfeld RM. 2014. Differential diagnosis of bipolar disorder and major depressive disorder. J Affect Disord. 169:12–16. doi:10.1016/S0165-0327(14)70004-7
   PubMed Web of Science ®Google Scholar
• Jefferson JW. 2005. Old versus new medications: how much should be taught? Acad Psychiatry. 29(2):162–166. doi:10.1176/appi.ap.29.2.162
   PubMed Web of Science ®Google Scholar
• Kendall T, Morriss R, Mayo-Wilson E, Marcus E, Guideline Development Group of the National Institute for Health and Care Excellence. 2014. Assessment and management of bipolar disorder: summary of updated NICE guidance. BMJ. 349:g5673. doi:10.1136/bmj.g5673
   PubMedGoogle Scholar
• Kessing LV, Hellmund G, Geddes JR, Goodwin GM, Andersen PK. 2011. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry. 199(1):57–63. doi:10.1192/bjp.bp.110.084822
   PubMed Web of Science ®Google Scholar
• Licht RW. 2012. Lithium: still a major option in the management of bipolar disorder. CNS Neurosci Ther. 18(3):219–226. doi:10.1111/j.1755-5949.2011.00260.x
   PubMed Web of Science ®Google Scholar
• Malhi GS, Outhred T, Morris G, Boyce PM, Bryant R, Fitzgerald PB, Hopwood MJ, Lyndon B, Mulder R, Murray G, et al. 2018. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary. Med J Aust. 208(5):219–225. doi:10.5694/mja17.00658
   PubMed Web of Science ®Google Scholar
• Manchia M, Hajek T, O'Donovan C, Deiana V, Chillotti C, Ruzickova M, Del Zompo M, Alda M. 2013. Genetic risk of suicidal behavior in bipolar spectrum disorder: analysis of 737 pedigrees. Bipolar Disord. 15(5):496–506. doi:10.1111/bdi.12088
   PubMed Web of Science ®Google Scholar
• Mauer S, Alahmari R, Vöhringer PA, Vergne DE, Lövdahl H, Correa E, Patkar A, Pae C, Strejilevich S, Dalley S, et al. 2014. International prescribing patterns for mood illness: the International Mood Network (IMN). International prescribing patterns for mood illness: the International Mood Network (IMN). J Affect Disord. 167:136–139. doi:10.1016/j.jad.2014.05.049
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, et al. 2011. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 68(3):241–251. doi:10.1001/archgenpsychiatry.2011.12
   PubMed Web of Science ®Google Scholar
• Noack CH, Trautner EM. 1951. The lithium treatment of maniacal psychosis. Med J Aust. 2(7):219–222. doi:10.5694/j.1326-5377.1951.tb68249.x
   PubMedGoogle Scholar
• Parabiaghi A, Barbato A, Risso P, Fortino I, Bortolotti A, Merlino L, D’Avanzo B. 2015. Lithium use from 2000 to 2010 in Italy: a population-based study. Pharmacopsychiatry. 48(3):89–94. doi:10.1055/s-0034-1398506
   PubMed Web of Science ®Google Scholar
• Paton C, Cookson J, Ferrier IN, Bhatti S, Fagan E, Barnes TRE. 2018. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age. BMJ Open. 8(4):e020450. doi:10.1136/bmjopen-2017-020450
   PubMed Web of Science ®Google Scholar
• Pisanu C, Papadima EM, Del Zompo M, Squassina A. 2018. Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics. Neurosci Lett. 669:24–31. doi:10.1016/j.neulet.2016.06.045
   PubMed Web of Science ®Google Scholar
• Rakofsky JJ, Dunlop BW. 2012. US psychiatric residents’ treatment of patients with bipolar disorder. J Clin Psychopharmacol. 32(2):231–236. doi:10.1097/JCP.0b013e31824857ad
   PubMed Web of Science ®Google Scholar
• Randall M, Lowe M, Aillon-Sohl L. 2016. What is the experience of psychiatry residents learning to prescribe? A qualitative research inquiry. J Ment Health. 25(2):122–125. doi:10.3109/09638237.2015.1078885
   PubMed Web of Science ®Google Scholar
• Reuveni I, Pelov I, Reuveni H, Bonne O, Canetti L. 2017. Cross-sectional survey on defensive practices and defensive behaviours among Israeli psychiatrists. BMJ Open. 7(3):e014153. doi:10.1136/bmjopen-2016-014153
   PubMed Web of Science ®Google Scholar
• Schaffer A, Isometsä ET, Tondo L, Moreno DH, Sinyor M, Kessing LV, Turecki G, Weizman A, Azorin JM, Ha K, et al. 2015. Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry. 49(9):785–802. doi:10.1177/0004867415594427
   PubMed Web of Science ®Google Scholar
• Severus E, Bauer M, Geddes J. 2018. Efficacy and effectiveness of lithium in the long-term treatment of bipolar disorders: an update 2018. Pharmacopsychiatry. 51(5):173–176. doi:10.1055/a-0627-7489
   PubMed Web of Science ®Google Scholar
• Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. 1999. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 156(8):1264–1266. doi:10.1176/ajp.156.8.1264
   PubMed Web of Science ®Google Scholar
• Tondo L, Alda M, Bauer M, Bergink V, Grof P, Hajek T, Lewitka U, Licht RW, Manchia M, Müller-Oerlinghausen B, et al. 2019. Clinical use of lithium salts: guide for users and prescribers. Int J Bipolar Disord. 7(1):16. doi:10.1186/s40345-019-0151-2
   PubMedGoogle Scholar
• Wieck A, Jones S. 2018. Dangers of valproate in pregnancy. BMJ. 361:k1609. doi:10.1136/bmj.k1609
   PubMedGoogle Scholar
• Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, et al. 2018. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 20(2):97–170. doi:10.1111/bdi.12609
   PubMed Web of Science ®Google Scholar
• Yatham LN. 2004. Newer anticonvulsants in the treatment of bipolar disorder. J Clin Psychiatry. 65:28–35.
   PubMed Web of Science ®Google Scholar
• Zhu MM, Li HL, Shi LH, Chen XP, Luo J, Zhang ZL. 2017. The pharmacogenomics of valproic acid. J Hum Genet. 62(12):1009–1014. doi:10.1038/jhg.2017.91
   PubMed Web of Science ®Google Scholar
• Zisook S, Benjamin S, Balon R, Glick I, Louie A, Moutier C, Moyer T, Santos C, Servis M. 2005. Alternate methods of teaching psychopharmacology. Acad Psychiatry. 29(2):141–154. doi:10.1176/appi.ap.29.2.141
   PubMed Web of Science ®Google Scholar
• Zivanovic O. 2017. Lithium: a classic drug-frequently discussed, but, sadly, seldom prescribed!. Aust N Z J Psychiatry. 51(9):886–896. doi:10.1177/0004867417695889
   PubMed Web of Science ®Google Scholar